Cargando…
Potential use of renin-angiotensin-aldosterone system inhibitors to reduce COVID-19 severity
SARS-CoV-2 infection and its clinical manifestations (COVID-19) quickly evolved to a pandemic and a global public health emergency. The limited effectivity of available treatments aimed at reducing virus replication and the lessons learned from other coronavirus infections (SARS-CoV-1 or NL63) that...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Sociedade Portuguesa de Cardiologia. Published by Elsevier España, S.L.U.
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9999244/ https://www.ncbi.nlm.nih.gov/pubmed/36893838 http://dx.doi.org/10.1016/j.repc.2022.02.014 |